Source: Nature
Part of: AI cracks hard problems in science and math →
AlphaGenome 2 predicts not just that a mutation exists, but where and how it changes cellular behavior—moving from static sequence cataloging to functional prediction at scale. The capability compresses years of wet-lab validation work into algorithmic inference, letting researchers prioritize which of millions of variants actually matter for disease and accelerating drug target discovery. This could shift how genetic risk is stratified in clinical practice.